SCHEMBL19959871

SCHEMBL19959871

S=P(c1ccc2ccccc2c1)(c1ccc2ccc3ccccc3c2c1)c1ccc2nc3c4ccccc4c4ccccc4n3c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.35
LMNA P02545 5/20 0.35
MAPT P10636 3/20 0.35
HSD17B10 Q99714 3/20 0.35
POLB P06746 2/20 0.35
TP53 P04637 2/20 0.35
ALDH1A1 P00352 10/20 0.34
HPGD P15428 6/20 0.34
AHR P35869 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HIF1A Q16665 1/20 0.32
CYP1B1 Q16678 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959835 0.96 KDM4E (0.37) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959922 0.94 KDM4E (0.38) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19965895 0.94 KDM4E (0.38) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959880 0.92 KDM4E (0.34) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959892 0.92 KDM4E (0.39) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959899 0.91 KDM4E (0.39) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959851 0.89 KDM4E (0.41) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959868 0.89 AHR (0.37) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959855 0.89 KDM4E (0.41) KDM4ELMNAMAPTHSD17B10POLB
SCHEMBL19959923 0.89 KDM4E (0.34) KDM4ELMNAMAPTHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885MAPT 1310/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885MAPT 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.